Skip to main navigation Skip to search Skip to main content

Combination of niraparib, cisplatin and twist knockdown in cisplatin-resistant ovarian cancer cells potentially enhances synthetic lethality through er-stress mediated mitochondrial apoptosis pathway

  • Entaz Bahar
  • , Ji Ye Kim
  • , Dong Chul Kim
  • , Hyun Soo Kim
  • , Hyonok Yoon

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Combination of niraparib, cisplatin and twist knockdown in cisplatin-resistant ovarian cancer cells potentially enhances synthetic lethality through er-stress mediated mitochondrial apoptosis pathway'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Neuroscience